15mg Thioplan Thiotepa Injection IP

15mg Thioplan Thiotepa Injection IP Specification

Life Span
24 months from date of manufacture

Packaging Type
Glass vial with flip-off seal, carton box

Dosage Form
Lyophilized powder for solution

Pacakaging (Quantity Per Box)
1 vial per box

Salt Composition
ThiotePa 15mg

Indication
Treatment of breast, ovarian, bladder, and other cancers

Origin of Medicine
India

Brand Name
Thioplan

Drug Type
Prescription Allopathic Medicine

Ingredients
Thiotepa

Physical Form
Injection

Function

Recommended For
Adults and children as prescribed by physician

Dosage
As directed by the oncologist or healthcare provider

Dosage Guidelines
Administered intravenously under medical supervision

Storage Instructions
Store below 25C, protect from light

Contraindications
Hypersensitivity to Thiotepa or any excipient

Marketed By
Celon Labs

Reconstitution Instructions
Dissolve in appropriate sterile solvent as per pack insert

Administration Route
Intravenous injection after reconstitution

Strength
15mg

Prescription Status
Schedule H - to be sold by retail on the prescription of a Registered Medical Practitioner only

Inactive Ingredients
Mannitol, Sodium Chloride (may vary)

Colour
White to off-white lyophilized powder

Regulatory Status
IP (Indian Pharmacopoeia) Grade

15mg Thioplan Thiotepa Injection IP Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
1000 Pieces Per Month

Delivery Time
7 Days

About 15mg Thioplan Thiotepa Injection IP

Strength	15mg
Manufacturer	Natco
Brand	Thioplan
Packaging Type	Box
Composition	Thiotepa
Pack Size	1ml
Treatment	Anti Cancer

Thioplan Injection is used in the treatment of cancers of brain, breast, lungs, and ovaries. It is used in combination with other cancer medicine during hematopoietic progenitor cell transplantation (HPCT). It may be also used to treat other conditions, as determined by the doctor.

Thioplan Injection is given as an IV infusion under the supervision of a healthcare professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include nausea, vomiting, hair loss, and mouth sores. Some serious side effects, which means they need immediate action involve anemia (low number of red blood cells). This medicine may reduce the number of blood cells in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with kidney, liver and heart function during treatment with this medicine.

Before taking it, tell your doctor if you have bleeding, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Focused Cancer Chemotherapy

Thioplan Thiotepa Injection IP is formulated specifically for cancer patients, targeting rapidly dividing cancer cells. It is commonly prescribed for breast, ovarian, bladder, and several other types of cancers, providing precise and effective chemotherapy under professional supervision.

Convenient and Safe Packaging

This injection comes in a glass vial with a flip-off seal, ensuring product sterility and integrity. Each box contains one vial, making dosing straightforward and reducing handling error risks. Proper storage below 25C and light protection preserve the medication's potency.

Administered by Healthcare Professionals

Thioplan is administered intravenously after proper reconstitution by a trained medical professional. The process is performed under strict medical supervision to optimize therapeutic outcomes and monitor for any potential adverse effects or allergic reactions.

FAQ's of 15mg Thioplan Thiotepa Injection IP:

Q: How should Thioplan Thiotepa 15mg Injection be administered?

A: Thioplan Thiotepa Injection is administered intravenously after being dissolved in a suitable sterile solvent as per the instructions provided in the pack insert. Administration must be carried out by a qualified healthcare professional in a clinical setting.

Q: What cancers is Thioplan Thiotepa Injection prescribed for?

A: This medication is primarily used for treating breast, ovarian, bladder, and various other malignancies, as determined by your oncologist based on your diagnosis and treatment plan.

Q: When should Thioplan Thiotepa Injection not be used?

A: The injection is contraindicated for individuals with known hypersensitivity to thiotepa or any of its excipients, including mannitol or sodium chloride. Inform your doctor about any allergies or past reactions before starting treatment.

Q: Where should the injection be stored before use?

A: Before use, store the vial below 25C and protect it from light. Do not freeze. Keep the vial in its original carton until time of reconstitution and administration to maintain medication stability.

Q: What is the process for reconstituting Thioplan Thiotepa Injection?

A: The lyophilized powder should be dissolved using the appropriate sterile solvent as specified in the pack insert. Only trained medical personnel should perform the reconstitution and administration procedures.

Q: Who is Thioplan Thiotepa Injection suitable for?

A: It is suitable for adults and children diagnosed with specific cancers and prescribed by a registered medical practitioner, especially oncologists.

Q: What are the main benefits of using Thioplan Thiotepa Injection?

A: Thioplan delivers effective antineoplastic therapy, aiming to inhibit cancer cell growth and manage tumor progression, often as a part of a comprehensive chemotherapeutic regimen.